43% of women in the US experience sexual dysfunction

  • Damage to blood vessels and smooth muscle tissue due to disease and lifestyle play a role in female sexual dysfunction (FSD)
  • Animal studies validate tissue damage affects FSD
  • Research is just beginning to focus on physical factors beyond emotional and hormonal
  • CMTH has files US patent application number #62319753 covering the treatment of female sexual dysfunction using stem cell and progenitor cell populations
  • Regenerates the smooth muscle and vasculature associated with clitoral and vaginal function
  • Pre-clinical research ongoing, clinical trials scheduled for 2018